Related Experiment Video
Updated: Jul 25, 2025
00:04
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
The Case Against Race-Based Quotas in Pharmaceutical Trials
1Angelo State University, San Angelo, TX, USA.
American Journal of Law & Medicine
|June 28, 2023
Summary
This article argues against racial quotas in pharmaceutical studies, finding them legally unsound and pragmatically insignificant. It suggests focusing on root causes to address health disparities effectively.
Area of Science:
- Health Law
- Pharmaceutical Research
- Bioethics
Background:
- The use of race in scientific investigation, particularly in pharmaceutical studies, is a complex issue with a troubling history.
- The U.S. Food and Drug Administration (FDA) approved BiDil, a drug for Black individuals, highlighting the debate around race-based treatments.
- Existing racial classification systems and calls for racial quotas in clinical trials warrant critical examination.
Purpose of the Study:
- To present a comprehensive case against the implementation of racial quotas in pharmaceutical studies.
- To analyze the legal and pragmatic implications of using racial quotas in drug research.
- To explore race-neutral alternatives for addressing health disparities in clinical trials.
Main Methods:
- Detailed examination of arguments for and against racial quotas in pharmaceutical trials.
- Legal analysis applying strict scrutiny standards to racial quotas.
- Evaluation of the purported benefits versus disadvantages of racial quotas.
Main Results:
- Racial quotas in pharmaceutical trials are unlikely to meet the strict scrutiny legal standard.
- The alleged benefits of racial quotas are insignificant when weighed against their disadvantages.
- The article provides a framework for assessing racial-classification issues in healthcare.
Conclusions:
- Racial quotas in pharmaceutical studies are legally and pragmatically flawed.
- Addressing the root causes of health disparities is more effective than focusing on outcomes.
- The findings support a shift towards race-neutral alternatives and synergistic approaches to diversity, equity, and inclusion in healthcare research.
Related Concept Videos
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
02:07Blind Procedures
10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K